Showing results (471-480 of 526) with videos related to

Sort By:
Pageof 53
Circulation|October 25, 2023
Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority TrialSung-Jin Hong, Seung-Jun Lee, Yongsung Suh, et al.
Journal of the American Heart Association|April 10, 2025
Distal Radial Access and Women: Implications for Access Site Outcomes in Coronary ProceduresJi Woong Roh, Seok-Jae Heo, Oh-Hyun Lee, et al.
Lipids|April 18, 2025
Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trialTae Oh Kim, Kyounghoon Lee, Jin-Man Cho, et al.
Clinical Therapeutics|April 12, 2022
Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical TrialHyungdon Kook, Cheol Woong Yu, Donghoon Choi, et al.
JACC. Asia|October 7, 2024
Widespread Use of Imaging-Guided PCI in Asia: Time for Extended ApplicationYongcheol Kim, Ju Hyeon Kim, Soon Jun Hong, et al.
Cell Reports|December 9, 2022
Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody responseMichelle K Ash, Pavan P Bhimalli, Byoung-Kyu Cho, et al.
European Heart Journal|May 15, 2024
Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trialsYong-Joon Lee, Sanghoon Shin, Sung Woo Kwon, et al.
Korean Circulation Journal|December 29, 2024
Feasibility of Distal Radial Access in High Bleeding Risk Patients Who Underwent Percutaneous Coronary InterventionIn Tae Jin, Ji Woong Roh, Oh-Hyun Lee, et al.
Med (New York, N.Y.)|August 17, 2024
Ticagrelor monotherapy in ST-elevation myocardial infarction: An individual patient-level meta-analysis from TICO and T-PASS trialsYong-Joon Lee, Deok-Kyu Cho, Jun-Won Lee, et al.
International Journal of Cardiology|October 4, 2015
Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trialPyung Chun Oh, Taehoon Ahn, Dong Woon Kim, et al.
Pageof 53